This dipeptide, comprising proline and glycine (N phenylacetyl-L-prolylglycine ethyl ester), was developed in Russia and patented in 1995. It is prescribed in Russia and neighbouring countries as a nootropic and neuro-protector. n addition, a study on mice showed Noopept to have anti-inflammatory effects linked to its antioxidant properties.

Noopept is recommended at doses of between one and three sublingual tablets a day and it's widely documented as safe with mild side effects observed only rarely at high doses (headaches, insomnia, nausea, fatigue). There is no dependency or interactions with other supplements or drugs that have been identified.

Arctic Plankton Oil is suitable for all sectors of the population for meeting recommended intakes for omega-3 fatty acids.

In addition, it is particularly recommended for the following groups of people:

• Those with a large waistline (excess abdominal fat).
• Those over 50 (to prevent cognitive decline and cardiovascular problems).
• Those suffering from chronic inflammation.
• Those with hypertension, hypertriglyceridaemia, hypercholesterolaemia or hyperglycaemia.
• Those suffering from fatigue or low mood.
• Those at risk of cardiovascular problems.

In theory, the body is able to produce EPA and DHA from plant-source omega-3 fatty acids, but this source has declined significantly over the last decades due to modern farming methods and changes in our diet (14). What’s more, the rate at which they’re converted is now very low as a result of our inappropriately-high consumption of omega-6 (15). Of far less benefit to the body, these fatty acids are nonetheless ubiquitous in modern processed foods and they mobilise all the enzymes (elongases and desaturases) needed for the conversion of plant-sourced omega-3s into DHA and EPA.

So if you decided to increase your intake of plant-sourced omega-3 fatty acids, you would not see any benefits unless you simultaneously made significant cuts to your omega-6 intake. The fact is, we actually need to consume the same amount of plant omega-3 as we do omega-6, but our actual consumption of omega-6 is 15-50 times greater than that of our plant-sourced omega-3. In excess, omega-6 displace omega-3 and invade cell membranes in their place, resulting in the formation of billions of pro-inflammatory molecules (16-17) which are thought to play a key role in the development and exacerbation of chronic diseases.

This adverse imbalance could be rectified through daily consumption of oily fish rich in EPA and DHA. Unfortunately, however, the level of contamination of these fish and the fact that they’re relatively inaccessible makes this an untenable option... Supplementing with EPA and DHA is thus the simplest and most effective way of rapidly restoring cell membranes to a healthy state.

Arctic Plankton Oil is produced from the species Calanus finmarchicus, a minuscule copepod which forms part of marine zooplankton. Measuring less than a millimetre but representing an enormous biological resource (it is without doubt one of the most abundant species on the planet in terms of biomass), Calanus finmarchicus is harvested from the Arctic in strict adherence to both the bioeconomic strategies of Scandinavian countries and the quotas fixed by the Institute of Marine Research. As this species inhabits the lowest trophic levels, there is no risk of the heavy metal contamination typically observed in oily fish.

In the cold waters of the Arctic, which is periodically covered in ice and isolated from pollution, it benefits from an idyllic setting providing the best possible conditions for reproduction and growth .

Click here to see the environment and conditions in which these copepods are harvested: https://www.youtube.com/watch?v=9X5W03gu7eA&t=7s